|
Thursday 29th August 2013 |
|
Clinical Trial Detrusor Overactivity Incontinence Quality of Life (QoL)
|
|
1. Université Paris-VI, Department of Urology, Paris, France, 2. Medical University of South Carolina, Department of Urology, Charleston, SC, USA, 3. Oakland University, William Beaumont School of Medicine, Royal Oak, MI, USA, 4. Allergan, Inc, Irvine, CA, USA
|
E
Emmanuel Chartier-Kastler
|